PolarCool

PolarCool signs first agreement in Slovakia with ice hockey club HC Košice

Källa: MFN
Neutral

Sammanfattning

PolarCool har tecknat sitt första avtal i Slovakien med ishockeyklubben HC Košice. Avtalet är strategiskt viktigt för att etablera sig på den slovakiska marknaden och stärker bolagets närvaro inom europeisk ishockey.

Analys

PolarCool fortsätter sin expansion inom europeisk ishockey genom att säkra sitt första avtal i Slovakien med HC Košice. Detta steg är strategiskt viktigt för att etablera bolaget på en ny marknad med stark ishockeytradition. Även om enskilda avtal kan ha begränsad finansiell påverkan, ses detta som en viktig milstolpe i PolarCool's långsiktiga tillväxtstrategi och ambition att stärka sin europeiska position.

Insikter

  • • Avtalet med HC Košice är en strategisk genombrott för PolarCool på den slovakiska marknaden.
  • • Bolaget ser detta som en viktig milstolpe för långsiktig tillväxt och europeisk expansion.
  • • HC Košice är en ledande klubb och förväntas agera som en viktig ambassadör för teknologin i Slovakien.

Med-tech company PolarCool AB (publ.) continues to expand its presence in European ice hockey and has now signed its first agreement in Slovakia. The Slovak club HC Košice becomes the first team in the top-tier, Tipsport league,  to include PolarCap® in its concussion management routines.

Slovakia has one of Central Europe's leading ice hockey leagues. With this establishment, PolarCool strengthens its presence within European ice hockey. The company is already active in several of Europe's top leagues, including Sweden, Finland, Germany, Austria, the United Kingdom, Switzerland, and the Czech Republic.

HC Košice's team doctor Michal Fečík comments:

-We look forward to offering our players acute treatment with PolarCap® in the event of a concussion. As the medical doctor of HC Košice, I see it as my obligation to provide my players with the best possible care. Including PolarCap®, a clinically evaluated treatment, was therefore an obvious choice.

PolarCool's CEO Erik Andersson comments:

-I am very pleased with HC Košice's commitment to player safety and that we have secured our first agreement for PolarCap® in Slovakia - a country with a strong ice hockey tradition. HC Košice is one of the country's leading clubs and will serve as an important ambassador for our technology in Slovakia. We look forward to the collaboration and expect more Slovak clubs to follow soon.

The two-year agreement with HC Košice represents a strategic breakthrough in the Slovak market. Although individual agreements may have limited financial impact, this marks an important step in PolarCool's long-term growth strategy and its ambition to strengthen its position in the European market.

For more information

Erik Andersson -  CEO PolarCool AB (publ.)                +46 - 738 60 57 00                                          E-mail: erik.andersson@polarcool.se

About PolarCool AB (publ.)

PolarCool AB (publ.) is a Swedish medical technology company focused on developing and marketing products in the sports medicine field. Its primary product, PolarCap®, is designed to reduce the impact of concussion through targeted brain cooling. PolarCool works with professional teams across Europe in rugby, football, and ice hockey and it shares are listed on Spotlight Stock Market.

Öppna PDF

Fler nyheter från PolarCool

Relaterade pressmeddelanden och bolagshändelser från samma bolag.

Se bolagssidan